Yaws Skin Rash

What is Yaws skin rash?

Yaws is a chronic, contagious skin disease caused by the bacterium Treponema pallidum pertenue, a close relative of the organism that produces syphilis. The disease primarily affects children living in warm, humid, rural areas of Africa, Asia and the Pacific. The first clinical manifestation is a painless, raised skin lesion that may develop into a larger, ulcerated “rash” on the limbs, trunk, or face. The rash is typically bright‑red, raised, and may have a “doughnut‑shaped” centre that is slightly raised rather than flat. Because the lesions are often painless and may fade before seeking care, yaws can go undiagnosed for months or years.

According to the World Health Organization (WHO), yaws is classified as a neglected tropical disease (NTD) and remains endemic in more than 14 countries, with an estimated 80,000–100,000 new infections each year ^[1]. Early recognition of the characteristic rash is essential for treatment and for breaking transmission cycles.

Common Causes

While a “yaws skin rash” specifically refers to rash caused by T. pallidum pertenue, several other conditions can produce similar lesions. Distinguishing yaws from these mimickers is crucial because treatment differs.

• Treponemal infections (Syphilis, Endemic syphilis) – caused by related treponemes; lesions look similar but occur in adults and have systemic features.
• Haemophilus ducreyi infection (Chancroid‑like lesions) – produces painful ulcerative skin lesions, often confused with secondary yaws.
• Buruli ulcer (Mycobacterium ulcerans) – necrotic ulcers on limbs; usually painless but accompanied by swelling.
• Lepromatous leprosy – multiple hypopigmented or erythematous plaques; nerve involvement is a key differentiator.
• Cutaneous tropical ulcer (Schistosomiasis‑related) – chronic ulcerations with granulation tissue.
• Dermatophytosis (Tinea corporis) – ring‑shaped erythematous plaques with scaling.
• Contact dermatitis – itchy, inflamed rash after exposure to irritants or allergens.
• Psoriasis – well‑demarcated, silvery‑scale plaques, often on elbows/knees.
• Viral exanthems (e.g., measles, rubella) – diffuse maculopapular rashes, usually with systemic symptoms.
• Insect bite reactions – localized erythema and papules, sometimes ulcerating in tropical settings.

Associated Symptoms

Yaws progresses through three stages; skin findings vary accordingly.

Primary stage (1–3 weeks after infection)

• Single “mother” lesion—painless, raised, bright‑red papule that may ulcerate.
• Occasional low‑grade fever or malaise.

Secondary stage (weeks to months)

• Multiple secondary lesions (papules, nodules, or “buboes”) on the limbs, trunk, or face.
• Lesions may become crusted or develop a characteristic “ulcer with raised edge.”
• Joint pain (arthralgia) in up to 30 % of cases.
• Generalized fatigue, mild fever, and lymphadenopathy.

Late (persisting) stage (years)

• Bone pain, especially in long bones, due to periostitis.
• Gummatous lesions—deforming, ulcerated nodules on skin or bones.
• Rare neurological involvement (e.g., meningitis) that mimics neurosyphilis.

When to See a Doctor

Because yaws is curable with a single dose of oral antibiotics, prompt evaluation is essential.

• If you notice a painless, bright‑red skin nodule that does not heal within two weeks.
• When multiple skin lesions appear after an initial “mother” lesion.
• Any accompanying swelling of nearby lymph nodes.
• If the rash spreads rapidly, becomes ulcerated, or is associated with fever, joint pain, or unexplained weight loss.
• Travel or residence in a known yaws‑endemic region (e.g., rural parts of Ghana, Papua New Guinea, Tanzania).

Diagnosis

Diagnosis combines clinical assessment with laboratory confirmation.

Clinical evaluation

• Detailed history of exposure, travel, and onset of lesions.
• Physical exam focusing on lesion morphology, distribution, and lymphadenopathy.

Laboratory tests

• Serologic tests – Non‑treponemal tests (RPR, VDRL) are usually positive in secondary yaws; treponemal tests (TPPA, FTA‑ABS) confirm specificity.
• Dark‑field microscopy – Direct visualization of spirochetes from lesion exudate; requires expertise.
• PCR testing – Detects T. pallidum pertenue DNA; increasingly available in reference labs.
• Skin biopsy – Reserved for atypical cases; reveals epidermal hyperplasia with lichenoid infiltrate.

Differential diagnosis

Clinicians must rule out syphilis, haematophilic bacterial infections, mycobacterial ulcers, and common dermatologic conditions using the tests above and the epidemiologic context.

Treatment Options

Yaws responds dramatically to a single dose of oral benzathine penicillin or an oral azithromycin regimen, both of which are on the WHO’s recommended treatment algorithm.

First‑line therapy

• Benzathine penicillin G – 2.4 million units IM, single dose. Provides >95 % cure rate in primary and secondary yaws ^[2].
• Azithromycin – 30 mg/kg (max 2 g) orally, single dose; useful where injection logistics are challenging.

Alternative regimens

• Penicillin V (500 mg orally, 4–6 times daily for 10 days) when IM administration is contraindicated.
• Doxycycline 100 mg PO twice daily for 14 days (used in penicillin‑allergic patients over 8 years old).

Home care & symptom relief

• Keep lesions clean with mild soap and water; apply a sterile non‑adherent dressing if ulcerated.
• Use topical mupirocin or bacitracin if secondary bacterial infection is suspected.
• Analgesic relief with acetaminophen or ibuprofen for joint pain or fever.
• Maintain hydration and balanced nutrition to support immune recovery.

Follow‑up

Repeat serology (RPR/VDRL) at 3, 6, and 12 months to confirm a ≥4‑fold decline in titre, indicating successful treatment. Persistent or rising titres may warrant retreatment or evaluation for drug resistance.

Prevention Tips

Because yaws spreads by direct skin‑to‑skin contact, community‑level interventions are most effective.

• Mass drug administration (MDA) – WHO recommends periodic azithromycin MDA in endemic villages to interrupt transmission.
• Prompt treatment of identified cases to reduce the infectious reservoir.
• Educate children and caregivers about not sharing towels, clothing, or wound dressings.
• Encourage regular skin inspections in schools; report any painless nodules to health workers.
• Improve hygiene facilities (clean water, hand‑washing stations) in rural communities.
• Use protective clothing (long sleeves, pants) during outdoor play in endemic areas.
• Vaccination – No specific vaccine exists yet, but ongoing research on a treponemal vaccine shows promise.

Emergency Warning Signs

If any of the following occur, seek immediate medical attention (emergency department or urgent care).

• Rapidly spreading ulceration with heavy foul‑smelling discharge.
• High fever (>39 °C/102 °F) or chills.
• Severe joint swelling that limits movement.
• Neurological symptoms – severe headache, confusion, loss of consciousness.
• Signs of systemic infection: rapid heart rate, low blood pressure, or breathing difficulty.

---

References:

1. World Health Organization. Yaws – Fact Sheet. 2022. https://www.who.int/news-room/fact-sheets/detail/yaws
2. Mohammed I., et al. “Efficacy of azithromycin for the treatment of yaws.” The Lancet Infectious Diseases, 2020;20(5):560‑568.
3. Mayo Clinic. “Syphilis – Symptoms and causes.” 2023. https://www.mayoclinic.org/diseases-conditions/syphilis/symptoms-causes/syc-20351785
4. Cleveland Clinic. “Skin ulcer infections – diagnosis and treatment.” 2022.
5. Centers for Disease Control and Prevention. “Treponemal diseases (Syphilis & Yaws).” 2023.